Microbot Medical (MBOT) Metrics: History & Chart

Microbot Medical Inc.(MBOT)

Medical - Devices · Hingham, MA

$1.11+0.03 (+3.27%)

Delayed quote: Oct 6, 2026, 12:00 PM EDT

About Microbot Medical Inc.

Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.

Hingham, MA

43 employees

www.microbotmedical.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Harel Gadot

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-14.41%
30D Total Return	-25.69%
YTD Total Return	-46.52%
1Y Total Return	-65.16%
3Y Total Return	-21.37%
5Y Total Return	-85.06%
10Y Total Return	-99.35%
15Y Total Return	-99.97%
20Y Total Return	-100.00%

2026	-46.52%
2025	+78.56%
2024	-31.70%
2023	-45.51%
2022	-59.86%
2021	+8.85%
2020

CAGR TTM	-64.98%
CAGR 3Y	-7.70%
CAGR 5Y	-31.63%
CAGR 10Y	-39.57%
CAGR 15Y	-41.47%
CAGR 20Y	-40.49%

PE Ratio	4.74
PE Ratio Avg TTM	6.87
PE Ratio Avg 3Y	6.87
Current VS TTM Avg	-30.99%
Current VS 3Y Avg	-30.99%
Current VS 5Y Avg	-30.99%

All Metrics

MBOT Valuation Metrics

MBOT Stock Price Metrics

MBOT Dividend Metrics

MBOT Growth Rate Metrics

MBOT Discounted Cash Flow Metrics

MBOT Returns By Period

MBOT Yearly Returns

MBOT Average Annual Returns By Period (CAGR)

MBOT Revenue Metrics

MBOT PE Ratio Metrics

MBOT PS Ratio Metrics

MBOT PB Ratio Metrics

MBOT Price to Free Cash Flow Ratio Metrics

MBOT Debt to Equity Ratio Metrics

MBOT PEG Ratio Metrics

MBOT FCF Yield

MBOT Earnings Yield

MBOT EBITDA Yield

MBOT OCF Yield

MBOT EV/EBIT Ratio Metrics

MBOT EV/EBITDA Ratio Metrics

MBOT EV/Assets Ratio Metrics

MBOT EV/Sales Ratio Metrics

MBOT Current Ratio Metrics

MBOT Quick Ratio Metrics

MBOT ROIC Metrics

MBOT Return on Assets Metrics

MBOT Return on Equity Metrics

MBOT Net Profit Margin Metrics

MBOT Gross Profit Margin Metrics

MBOT Tax Rate Metrics

PS Ratio	207.70
PS Ratio Avg TTM	825.85
PS Ratio Avg 3Y	825.85
Current VS TTM Avg	-74.85%
Current VS 3Y Avg	-74.85%
Current VS 5Y Avg	-74.85%

PB Ratio	1.04
PB Ratio Avg TTM	1.54
PB Ratio Avg 3Y	2.14
Current VS TTM Avg	-32.61%
Current VS 3Y Avg	-51.46%
Current VS 5Y Avg	-60.81%

PFCF Ratio	4.68
PFCF Ratio Avg TTM	8.72
PFCF Ratio Avg 3Y	8.77
Current VS TTM Avg	-46.31%
Current VS 3Y Avg	-46.61%
Current VS 5Y Avg	-46.61%

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.01
Debt/Equity Ratio Avg 3Y	0.02
Current VS TTM Avg	+21.31%
Current VS 3Y Avg	-42.94%
Current VS 5Y Avg	-65.54%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	21.36%
FCF Yield Avg TTM	10.51%
FCF Yield Avg 3Y	10.34%
Current VS TTM Avg	+103.15%
Current VS 3Y Avg	+106.58%
Current VS 5Y Avg	+106.58%

Earnings Yield	21.09%
Earnings Yield Avg TTM	14.92%
Earnings Yield Avg 3Y	14.92%
Current VS TTM Avg	+41.39%
Current VS 3Y Avg	+41.39%
Current VS 5Y Avg	+41.39%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	11.43
Ev/Ebit Ratio Avg TTM	24.86
Ev/Ebit Ratio Avg 3Y	25.02
Current VS TTM Avg	-54.02%
Current VS 3Y Avg	-54.32%
Current VS 5Y Avg	-54.32%

Ev/Ebitda Ratio	386.34
Ev/Ebitda Ratio Avg TTM	310.55
Ev/Ebitda Ratio Avg 3Y	191.07
Current VS TTM Avg	+24.41%
Current VS 3Y Avg	+102.20%
Current VS 5Y Avg	+124.81%

Ev/Assets Ratio	0.95
Ev/Assets Ratio Avg TTM	1.45
Ev/Assets Ratio Avg 3Y	1.61
Current VS TTM Avg	-34.37%
Current VS 3Y Avg	-40.90%
Current VS 5Y Avg	-49.74%

Ev/Sales Ratio	201.12
Ev/Sales Ratio Avg TTM	807.14
Ev/Sales Ratio Avg 3Y	807.14
Current VS TTM Avg	-75.08%
Current VS 3Y Avg	-75.08%
Current VS 5Y Avg	-75.08%

Current Ratio	18.56
Current Ratio Avg TTM	20.82
Current Ratio Avg 3Y	11.77
Current VS TTM Avg	-10.83%
Current VS 3Y Avg	+57.65%
Current VS 5Y Avg	+78.86%

Quick Ratio	17.82
Quick Ratio Avg TTM	20.50
Quick Ratio Avg 3Y	11.65
Current VS TTM Avg	-13.10%
Current VS 3Y Avg	+52.89%
Current VS 5Y Avg	+72.91%

ROIC	(26.51%)
ROIC Avg 3Y	(119.84%)
ROIC Avg 5Y	(127.03%)
Current VS 3Y Avg	+77.88%
Current VS 5Y Avg	+79.13%
Current VS 10Y Avg	+71.15%

ROA	(22.27%)
ROA Avg TTM	(6.31%)
ROA Avg 3Y	(23.82%)
Current VS TTM Avg	-252.83%
Current VS 3Y Avg	+6.52%
Current VS 5Y Avg	+13.07%

ROE	(23.70%)
ROE Avg TTM	(23.68%)
ROE Avg 3Y	(124.68%)
Current VS TTM Avg	-0.09%
Current VS 3Y Avg	+80.99%
Current VS 5Y Avg	+81.98%

Net Profit Margin	(4722.25%)
Net Profit Margin Avg TTM	(1166.21%)
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	-304.92%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	(52.98%)
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	+100.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	-100.00%